Recent News

By Category: Research

Discovery may lead to vaccine for all 4 types of dengue

(Futurity) Researchers have discovered a new target for human antibodies that may lead to a vaccine for all four types of dengue virus—and may also have potential for vaccine development for other diseases, including SARS and HIV. Creating a vaccine that protects people from the four types of dengue virus has frustrated scientists for decades. Read More »

March 11, 2014
| Filed under Agents & Toxins, Countermeasures, and Research
Share

Vinegar Kills Tuberculosis and Other Mycobacteria

(Global Biodefense) The active ingredient in vinegar, acetic acid, can effectively kill mycobacteria, even highly drug-resistant Mycobacterium tuberculosis, an international team of researchers from Venezuela, France, and the US reports in mBio, the online open-access journal of the American Society for Microbiology. Acetic acid might be used as an inexpensive and non-toxic disinfectant against drug-resistant Read More »

March 11, 2014
| Filed under Europe, North America, South America, Agents & Toxins, Countermeasures, International, and Research
Share

Incorporating Antimicrobial Polymers to Protect Warfighters

(Global Biodefense) A multi-institution team, managed by DTRA CB’s Dr. Brian Pate and including David Whitten and other inventors from the University of New Mexico, University of Florida, Duke University, and the U.S. Army Natick Soldier Research, Development & Engineering Center (NSRDEC), was issued a patent on materials incorporating antimicrobial polymers. In the patent application, Read More »

March 11, 2014
| Filed under Biosafety and Research
Share

BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection

(MarketWatch) BioCryst Pharmaceuticals, Inc. BCRX today announced the online publication in the journal Nature of extensive laboratory and nonclinical characterizations of BCX4430, including efficacy results in animal models of infection with Marburg virus and Ebola virus, two highly virulent pathogens responsible for viral hemorrhagic fever diseases. The Nature online publication, “Protection against filovirus diseases by Read More »

March 3, 2014
| Filed under Agents & Toxins and Research
Share

Deadly Immune ‘Storm’ Caused by Emergent Flu Infections

(Global Biodefense) Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction—a “cytokine storm”—that can both sicken and kill patients who are infected with certain strains of flu virus. Their findings also clarify the workings of a potent new class of anti-inflammatory compounds that prevent this immune overreaction in Read More »